PTC Therapeutics Inc

NASDAQ:PTCT   4:00:00 PM EDT
48.84
-1.00 (-2.01%)
6:58:50 PM EDT: $50.00 +1.16 (+2.38%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.87B
Current PE6.51
Forward PE 6.51
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$172.08 Million
Adjusted EPS-$1.06
See more estimates
10-Day MA$49.75
50-Day MA$48.23
200-Day MA$45.73
See more pivots

PTC Therapeutics Inc Stock, NASDAQ:PTCT

500 Warren Corporate Center Drive, Warren, New Jersey 07059
United States of America
Phone: +1.908.222.7000
Number of Employees: 939

Description

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.